These weight loss drugs are expensive out of pocket, though. Even with insurance, high co-pays can also limit who has access ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

With so many weight loss medications on the market, it's easy to feel overwhelmed by the options. From brand-name heavy ...

The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.

Eli Lilly and Company LLY announced that its popular obesity drug, Zepbound (tirzepatide) demonstrated more weight loss than ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to ...

After a stellar FY24 performance, Natco Pharma’s stock has taken a hit. What’s next for the company as it faces crucial ...

Here’s how it works. The Surface Pen and Surface Slim Pen 2 are the best options for modern Surface PCs; I've been using the former for years without issue, and the latter adds wireless charging ...

The Pittsburgh Penguins don’t like comfortable, and they surely don’t make anything easy. After converting nearly every chance and racing to a 5-1 lead over the Vancouver Canucks, the Penguins watched ...

WASHINGTON (Reuters) -U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more than 7 million people with Medicare and Medicaid ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...